Abbott's Tacrolimus assay provides consistent medication monitoring for organ ... News-Medical.net A new study published in the journal Clinical Chemistry reported Abbott's (NYSE: ABT) ARCHITECT® Tacrolimus assay provides accurate and consistent medication monitoring for patients taking tacrolimus, an immunosuppressive medication, after receiving ... |
